Delivery Order SPE2DX22D0010-SPE2D826FAP57
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 11, 2025, for the supply of Mydayis capsules 50mg to support federal medical procurement needs. This firm fixed price delivery order, valued at $6,302.72 with an ultimate completion date of September 12, 2025, was competitively awarded without set-aside designation to the Defense Logistics Agency's Medical Supply Chain division. The place of...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,236.22 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $125,467.20 by the Defense Logistics Agency's Medical Supply Chain on October 22, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of October 23, 2025, and involves no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,983.52 by the Defense Logistics Agency's Medical Supply Chain on August 16, 2025, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed price delivery order under a competitive procurement with no set-aside designation. The award is a child contract issued under AmerisourceBergen's significant Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,671.88 on June 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. The competitively awarded, firm fixed-price contract carries an ultimate completion date of June 20, 2025, and represents a child order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order falls within...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,353.67 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a non-set-aside award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,240.98 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,380.43 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is non-competitive and carries an ultimate completion date of August 5, 2025. The award reflects AmerisourceBergen's established role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,756.24 by the Defense Logistics Agency's Medical Supply Chain on September 18, 2025. The contract, which represents a child order under a larger indefinite delivery vehicle, involves firm fixed pricing with no set-aside designation and an ultimate completion date of September 19, 2025. As a critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,036.80 on October 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price contract, which is a child award under a larger indefinite delivery contract vehicle, requires completion by October 14, 2025. The award was competitively procured without set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAP57Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order on October 24, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of MYDAYIS Capsules 50mg, a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract is valued at $4,246.35 and features firm fixed pricing with a delivery completion date of October 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts encompasses a wide range of pharmaceutical products and medical supplies delivered through the Defense Logistics Agency. All reviewed contract awards have been competitively awarded with firm fixed pricing structures, demonstrating AmerisourceBergen's capability to meet federal procurement requirements and serve customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/24/25 |